WallStreetZenWallStreetZen

NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NBIX

Based on 14 analysts offering 12 month price targets for Neurocrine Biosciences Inc

Min Forecast
$115.00-7.55%
Avg Forecast
$157.71+26.79%
Max Forecast
$185.00+48.73%

Should I buy or sell NBIX stock?

Based on 14 analysts offering ratings for Neurocrine Biosciences Inc.

Strong Buy
Strong Buy
8 analysts 57.14%
Buy
5 analysts 35.71%
Hold
1 analysts 7.14%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NBIX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NBIX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NBIX stock forecasts and price targets.

NBIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-02
lockedlocked$00.00+00.00%2025-05-06
lockedlocked$00.00+00.00%2025-05-06
lockedlocked$00.00+00.00%2025-05-06
lockedlocked$00.00+00.00%2025-05-06
Canaccord Genuity
Bottom 3%
3
Strong BuyMaintains$160.00+28.63%2025-05-06
Needham
Top 8%
93
BuyMaintains$139.00+11.75%2025-05-06
Evercore ISI Group
Top 22%
79
BuyMaintains$185.00+48.73%2025-04-24
HC Wainwright & Co.
Top 5%
96
BuyMaintains$168.00+35.06%2025-04-22
JP Morgan
Bottom 5%
5
Strong BuyMaintains$184.00+47.92%2025-03-26

1 of 2

Forecast return on equity

Is NBIX forecast to generate an efficient return?

Company
35.95%
Industry
30.74%
Market
90.47%
NBIX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NBIX forecast to generate an efficient return on assets?

Company
24.72%
Industry
15.4%
NBIX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NBIX earnings per share forecast

What is NBIX's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$3.79+25.03%
Avg 2 year Forecast
$5.87+93.59%
Avg 3 year Forecast
$7.53+148.47%
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NBIX revenue forecast

What is NBIX's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$2.7B+10.36%
Avg 2 year Forecast
$3.1B+26.53%
Avg 3 year Forecast
$3.5B+44.62%
NBIX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NBIX earnings growth forecast

How is NBIX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
36.08%
Industry
25.78%
Market
15.33%
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NBIX revenue growth forecast

How is NBIX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
13%
Industry
4.14%
Market
9.68%
NBIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NBIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NBIX vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
NBIX$124.39$157.71+26.79%Strong Buy
RDY$15.80$16.90+6.96%Strong Buy
VTRS$8.92$10.40+16.59%Hold
RGC$595.10N/AN/A
ELAN$13.81$15.40+11.51%Buy
View Top Pharmaceutical Stocks

Neurocrine Biosciences Stock Forecast FAQ

Is Neurocrine Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: NBIX) stock is to Strong Buy NBIX stock.

Out of 14 analysts, 8 (57.14%) are recommending NBIX as a Strong Buy, 5 (35.71%) are recommending NBIX as a Buy, 1 (7.14%) are recommending NBIX as a Hold, 0 (0%) are recommending NBIX as a Sell, and 0 (0%) are recommending NBIX as a Strong Sell.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.

What is NBIX's earnings growth forecast for 2025-2027?

(NASDAQ: NBIX) Neurocrine Biosciences's forecast annual earnings growth rate of 36.08% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 25.78%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Neurocrine Biosciences's earnings in 2025 is $305,800,000.On average, 12 Wall Street analysts forecast NBIX's earnings for 2025 to be $374,912,216, with the lowest NBIX earnings forecast at $306,794,042, and the highest NBIX earnings forecast at $435,449,608. On average, 12 Wall Street analysts forecast NBIX's earnings for 2026 to be $580,513,707, with the lowest NBIX earnings forecast at $414,666,786, and the highest NBIX earnings forecast at $748,181,599.

In 2027, NBIX is forecast to generate $745,074,072 in earnings, with the lowest earnings forecast at $496,808,416 and the highest earnings forecast at $880,795,798.

What is NBIX's revenue growth forecast for 2025-2027?

(NASDAQ: NBIX) Neurocrine Biosciences's forecast annual revenue growth rate of 13% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.14%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Neurocrine Biosciences's revenue in 2025 is $2,412,600,000.On average, 11 Wall Street analysts forecast NBIX's revenue for 2025 to be $263,497,782,306, with the lowest NBIX revenue forecast at $258,102,858,560, and the highest NBIX revenue forecast at $267,158,231,090. On average, 11 Wall Street analysts forecast NBIX's revenue for 2026 to be $302,099,004,533, with the lowest NBIX revenue forecast at $278,754,056,219, and the highest NBIX revenue forecast at $318,472,008,760.

In 2027, NBIX is forecast to generate $345,308,174,306 in revenue, with the lowest revenue forecast at $306,865,297,390 and the highest revenue forecast at $376,451,134,407.

What is NBIX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: NBIX) forecast ROA is 24.72%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.4%.

What is NBIX's Price Target?

According to 14 Wall Street analysts that have issued a 1 year NBIX price target, the average NBIX price target is $157.71, with the highest NBIX stock price forecast at $185.00 and the lowest NBIX stock price forecast at $115.00.

On average, Wall Street analysts predict that Neurocrine Biosciences's share price could reach $157.71 by Jun 2, 2026. The average Neurocrine Biosciences stock price prediction forecasts a potential upside of 26.79% from the current NBIX share price of $124.39.

What is NBIX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: NBIX) Neurocrine Biosciences's current Earnings Per Share (EPS) is $3.03. On average, analysts forecast that NBIX's EPS will be $3.79 for 2025, with the lowest EPS forecast at $3.10, and the highest EPS forecast at $4.40. On average, analysts forecast that NBIX's EPS will be $5.87 for 2026, with the lowest EPS forecast at $4.19, and the highest EPS forecast at $7.56. In 2027, NBIX's EPS is forecast to hit $7.53 (min: $5.02, max: $8.90).

What is NBIX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: NBIX) forecast ROE is 35.95%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.